TheEdgeResearch
Home / Stocks / PRGO

Perrigo Company plc (PRGO)

NYSE Healthcare Drug Manufacturers - Specialty & Generic
$12.49 ▼ -2.79%
Market Cap
$1.73B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.54
52-Wk Range
9.23-24.61
CEO
Albert A. Manzone
Country
IE
Currency
USD

Perrigo Company plc operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Dublin, DU, IE. The stock last traded at $12.49, down 2.79% on the session, giving a market capitalisation of $1.73B. On trailing twelve-month figures it carries a trailing P/E of -1.00, a net margin of -41.9%. Its beta of 0.54 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-1.00
Price / Sales
0.42
Price / Book
0.69
EV / EBITDA
-3.77
Gross margin
33.3%
Operating margin
5.2%
Net margin
-41.9%
Return on equity
Debt / equity
1.31
Current ratio
2.32
Dividend yield
9.3%
Payout ratio
-11.5%
Company profile
Exchange
New York Stock Exchange
Employees
8,100
IPO date
1991-12-17
Headquarters
Dublin, DU, IE
About Perrigo Company plc

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Comparable companies

Perrigo Company plc is most often compared with the following Healthcare names:

ATECBHCFOLDHCMHTFLLIVNSGRYSRRKSUPNTARS
More research on PRGO
PRGO technical analysis PRGO TheEdge Score Compare against peers
Open full interactive analysis & DCF →